novo nordisk weight loss - Search News

News

Novo Nordisk to sell weight-loss drug for $499

ABC News on MSN · 15h

Novo Nordisk slashes price of weight loss drugs

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general to exit in Hegseth’s latest shake-up of Pentagon

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients

Fox Business on MSN · 1d

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

16h

Top pharma companies work to launch first weight-loss pill

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

1don MSN

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

1d

Weight-loss drug Wegovy launches in South Africa

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

1d

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

1don MSN

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

Straight Arrow News (English) on MSN13h

Ozempic to cost much less for cash customers

The maker of Ozempic is slashing prices for U.S. patients who pay cash, a major shift in the fast-growing market for the drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results